Ashish Goyal

9PUBLICATIONS
17CO-AUTHORS
Epidemiological modellingMedical devicesPreventative health careInnate immunityHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 08, 2026
Modeling predicts shortening of DAA treatment duration to 5 weeks in individuals with recent or chronic infection with HCV RNA negativity at day 7 on treatment.

|Jan 12, 2022
Estimation of the in vivo neutralization potency of eCD4Ig and conditions for AAV-mediated production for SHIV long-term remission.

Ashish Goyal, Matthew Gardner, Bryan T Mayer

|Oct 26, 2021
Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 Transmission.

David A Swan, Ashish Goyal, Chloe Bracis

|Apr 03, 2021
Endogenously Produced SARS-CoV-2 Specific IgG Antibodies May Have a Limited Impact on Clearing Nasal Shedding of Virus during Primary Infection in Humans.

Shuyi Yang, Keith R Jerome, Alexander L Greninger

|Oct 31, 2020
HIV influences clustering and intracellular replication of hepatitis C virus.

Ashish Goyal, Alan S Perelson, Abraham J Kandathil

|Oct 24, 2020
Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response.

Ashish Goyal, E Fabian Cardozo-Ojeda, Joshua T Schiffer

Pageof 2

Frequent Collaborators

2 joint publications

E Fabian Cardozo-Ojeda

2 joint publications

Joshua T Schiffer

1 joint publications

John M Murray

1 joint publications

Alan S Perelson